Thermo Fisher Scientific (TMO) Stock
Key stats
- Market cap
- $256.24B
- Price / Earnings ratio
- 35.9x
- EPS (TTM)
- $18.62
- Volume
- Loading
- 52-week high
- $705.79
- 52-week low
- $435.27
- Dividend yield
- 0.27%
- Dividend amount (latest)
- $0.47
- EPS vs analyst estimate
- +5.3%Q3 FY25 · $5.79 vs $5.50
Source: third-party data provider, as of October 29, 2026
EPS estimate: analyst consensus
Compare with TMO
Recent news

Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
TMO

TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
TMO

Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
TMO

Thermo Fisher Scientific Q3 Earnings Call Highlights
Thermo Fisher Scientific Q3 Earnings Call Highlights
TMO
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 63.90
- MACD 12/26/9
- 12.39
- EMA 9 of MACD
- 12.03
- MACD histogram
- 0.36
- SMA 50
- $651.34
- Price above SMA 50
- EMA 50
- $648.77
- Price above EMA 50
- SMA 200
- $550.48
- Price above SMA 200
- EMA 200
- $581.16
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 28, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 9 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $6.15 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors
TMO

TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market
TMO

Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics
TMO

Thermo Fisher Scientific Q3 Earnings Call Highlights
Thermo Fisher Scientific Q3 Earnings Call Highlights
TMO

Thermo Fisher posts higher third-quarter revenue and earnings as margins improve
Thermo Fisher posts higher third-quarter revenue and earnings as margins improve
TMO

Medical Giants Thermo Fisher, Danaher Reverse Higher — What Investors Are Seeing
Medical Giants Thermo Fisher, Danaher Reverse Higher — What Investors Are Seeing
TMO

Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates
TMO

Thermo Fisher Scientific Reports Third Quarter 2026 Results
Thermo Fisher Scientific Reports Third Quarter 2026 Results
TMO

Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again
Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again
TMO

What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
TMO
News tone: automated (AI) classification of the article's content, not a price prediction.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Marc N. Casper | Chairman & CEO | 1968 |
| Mr. Gianluca Pettiti | President, COO & President of Products and Technologies | 1979 |
| Mr. James R. Meyer | Senior VP & CFO | 1980 |
| Mr. Joseph R. Holmes | VP & Chief Accounting Officer | 1980 |
| Mr. Ryan J. Snyder | Senior VP & Chief Information Officer | — |
| Dr. Karen E. Nelson Ph.D. | Chief Scientific Officer | — |
| Mr. Rafael Tejada | Vice President of Investor Relations | — |
| Mr. Thomas Bailey Shropshire Jr. | Senior VP and General Counsel | — |
| Ms. Sandy B. Pound | VP & Chief Communications Officer | — |
| Mr. Alan J. Malus | Senior Vice President of Strategy & Corporate Development | 1960 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of October 29, 2026
Technical indicators
- RSI 14
- 63.90
- MACD 12/26/9
- 12.39
- EMA 9 of MACD
- 12.03
- MACD histogram
- 0.36
- SMA 50
- $651.34
- Price above SMA 50
- EMA 50
- $648.77
- Price above EMA 50
- SMA 200
- $550.48
- Price above SMA 200
- EMA 200
- $581.16
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 28, 2026. Technical data, not a recommendation.
Analyst views
9 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $730.00
- Average
- $761.56
- High
- $810.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -0.4 | +6.6 | ||||||||||
| 2022 | -9.9 | -8.5 | +8.8 | -6.7 | +4.0 | -2.3 | +9.1 | -7.5 | -7.9 | -1.7 | +8.2 | -2.5 |
| 2023 | +3.1 | -7.8 | +7.0 | -2.7 | -7.3 | +0.5 | +5.7 | +2.1 | -9.2 | -10.3 | +12.4 | +7.0 |
| 2024 | -1.0 | +3.3 | +0.8 | -1.5 | -1.2 | -2.9 | +13.2 | -1.1 | +2.0 | -10.9 | -5.1 | -1.8 |
| 2025 | +14.4 | -10.9 | -5.0 | -11.2 | -4.1 | +2.3 | +11.0 | +6.4 | -0.5 | +6.9 | +4.6 | -1.0 |
| 2026 | -2.3 | -10.4 | -3.4 | -3.2 | +5.0 | +1.5 | +11.9 | +7.5 | +12.4 | +7.9 |
Corporate actions
Upcoming
No upcoming corporate actions for TMO



